PERRIGO COMPANY | 91,04 Euro | -0,42 -0,46 % | |
| WKN: 883878 ISIN: US7142901039 Ticker-Symbol: PGO | Stuttgart | 24.05.13 | 17:07 Uhr |
Branche PharmaAktienmarkt NASDAQ-100S&P 500 NASDAQ Biotech |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 23.05. | Perrigo to transfer stock to NYSE | - | Yahoo-USA | |
| 23.05. | Perrigo to switch to NYSE from Nasdaq | - | Globes | |
| 23.05. | PERRIGO CO - 8-K, Current Report | - | SEC Filings | |
| 23.05. | Perrigo To Transfer Common Stock Listing To NYSE | 34 | PR Newswire | |
| ALLEGAN, Mich., May 23, 2013 /PRNewswire/ --Perrigo Company (Nasdaq: PRGO; TASE) today announced that it is transferring the listing of its U.S. traded common stock to the New York Stock Exchange... Mehr lesen zu: Perrigo To Transfer Common Stock Listing To NYSE | ||||
| 15.05. | Perrigo Looks to Continue to Trade Above its Annual-High Share Price Today | 2 | SmarTrend | |
| 13.05. | Perrigo Launches First-Ever Industry Marketing Campaign For Store Brand OTC Medications | 38 | PR Newswire | |
| ALLEGAN, Mich., May 13, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced it has kicked off a broad industry marketing and communications campaign to raise awareness for, andconsumer... Mehr lesen zu: Perrigo Launches First-Ever Industry Marketing Campaign For Store Brand OTC Medications | ||||
| 12.05. | Perrigo to hold $600m debt offering | 1 | Globes | |
| 07.05. | Perrigo Management Discusses Q3 2013 Results - Earnings Call Transcript | - | Seeking Alpha | |
| 07.05. | Earnings Miss at Perrigo | 5 | Zacks | |
| 07.05. | Tue: Perrigo fails to depress flat market | 1 | Globes | |
| 07.05. | Perrigo reports record revenue, but lower profit | 1 | Globes | |
| 07.05. | PERRIGO CO - 10-Q, Quaterly Report | 1 | SEC Filings | |
| 07.05. | PERRIGO CO - 8-K, Current Report | - | SEC Filings | |
| 07.05. | BRIEF-Perrigo shares down following results | - | Reuters.com | |
| 07.05. | Perrigo Reports Record Revenue and Adjusted Earnings | 127 | PR Newswire | |
| ALLEGAN, Mich., May 7, 2013 /PRNewswire/ --Perrigo Company (Nasdaq: PRGO; TASE: PRGO) today announced results for its third quarter ended March 30, 2013.
(Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO... Mehr lesen zu: Perrigo Reports Record Revenue and Adjusted Earnings | ||||
| 07.05. | Perrigo - A Healthy Bet For Your Portfolio | 2 | Seeking Alpha | |
| 06.05. | Perrigo Likely to Report In Line Earnings | 2 | Zacks | |
| 03.05. | Perrigo Bullish Moving Average Crossover Alert | - | SmarTrend | |
| 03.05. | Relatively High Sales per Share Detected in Shares of Perrigo in the Pharmaceuticals Industry | - | SmarTrend | |
| 02.05. | Perrigo Company Announces Quarterly Dividend | 32 | PR Newswire | |
| ALLEGAN, Mich., May 2, 2013 /PRNewswire/ --Perrigo Company (Nasdaq: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on June 18, 2013... Mehr lesen zu: Perrigo Company Announces Quarterly Dividend | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| NOVO NORDISK | 129,40 | -1,15 % | Novo Nordisk: Liraglutide Leads to Weight Loss in Study |
| NOVARTIS | 57,25 | +0,35 % | Novartis: Neue Studiendaten belegen Wirkung von COPD-Franchise |
| GLAXOSMITHKLINE | 20,475 | +1,01 % | From Novel Research to Innovative Medicines: GlaxoSmithKline Launches Discovery Fast Track Competition for Academic Researchers |
| PFIZER | 22,452 | -0,10 % | Pfizer spaltet Tierarzneisparte Zoetis endgültig ab |
| CELGENE | 94,61 | -1,50 % | Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE sNDA in Advanced Pancreatic Cancer |
